News

iPRIME members Dr. Loran Erickson and Dr. John Lukens received an NOA supplement for their project “IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis”.  Congratulations to their team for their excellent work investigating the link between … Read More

Dr. Stefan Bekiranov, one of three PI’s of iPRIME &  Dr. Aidong Zhang, recipient of an iPRIME seed fund, have been awarded an NSF grant titled “An Explainable Machine Learning Platform for Single Cell Data Analysis” — this great work … Read More

The first iPRIME Symposium occurred on April 18th, 2023 with great success.  This program in Prominence to Preeminence, with support from the Vice President for Research at UVA showcased our successes in supporting their research. Over 60 attendees heard great … Read More

The immunology, imaging, informatics Precision ImmunoMedicine (iPRIME) initiative announces our iPRIME Fellowship Awards. This award will support innovative collaborative projects between students in biological and medical sciences and students in data science. Proposals may budget up to $15,000 and stipend … Read More

Brett Ransegnola (McNamara lab) and Meritxell Nus (Mallat lab in Cambridge, UK) have been awarded a $50K Leducq Transatlantic Network of Excellence to study the role of Id3 in marginal zone B cells.   They recently met in NYC with the … Read More

We are excited to announce that two of the Co-PI’s of the iPRIME initiative, Dr. Coleen McNamara and Dr. Angela Taylor, have received a Leducq International Network of Excellence Award.  They, along with other experts, will us this prestigious CHECKPOINT … Read More

Due to the sad events on Sunday, the iPRIME Launch Symposium on November 15 will be cancelled. We hope to reschedule at a future date.

We are excited to welcome Dr. Antonio Abbate to the University of Virginia School of medicine Cardiovascular Research Center.  Dr. Abbate is one of the world’s leading experts in precision Immunomedicine.  Welcome to UVA, Dr. Abbate! Dr. Antonio Abbate joined … Read More

iPRIME Investigators have partnered with colleagues from the La Jolla Institute (LJI) to utilize single cell multi-omic analysis of human circulating immune cells to identify the B cell subtype in humans that is associated with IgE sensitization to alpha gal … Read More

The research project seeks to understand the effects of IgE to alpha-gal on atherosclerotic plaque development and define immune mechanisms mediating IgE sensitization to alpha-gal linked to atherosclerotic cardiovascular disease in mice and humans. As part of the iPRIME initiative, … Read More